Shareholders' Equity (Tables)

6 Months Ended

Jun. 30, 2015

Other information pertaining to share-based activity during the three and six months ended June 30, 2015 and 2014 was as follows (in thousands):



	Three Months Ended June 30,				Six Months Ended June 30,
	2015		2014		2015		2014
Share-based compensation expense	$	3,883	$	2,506	$	7,592	$	4,964
Fair value of shares vested	1,746		1,183		13,220		10,358
Cash received from option exercises	334		1,158		2,080		1,646
Tax benefit from exercises of share based awards	216		363		3,533		2,090

A summary of the status of non-vested restricted shares at June 30, 2015 and changes during the six months ended June 30, 2015 is as follows:



			Weighted
	Number		Average
	of Shares		Grant Price
Non-vested shares at December 31, 2014	668,109		$	33.51
Shares granted	313,498		56.19
Shares vested	(233,831	)	28.19
Shares forfeited	(6,983	)	39.88
Non-vested shares at June 30, 2015	740,793		$	44.73

A summary of stock option activity for the six months ended June 30, 2015 is summarized as follows:



					Weighted
			Weighted		Average
			Average		Remaining
	Number		Exercise		Contractual
	of Shares		Price		Term (in years)
Outstanding at December 31, 2014	158,721		$	22.89	1.7
Options exercised with total intrinsic value of $3.5 million	(90,012	)	23.09
Options terminated	(5,000	)	25.76
Outstanding, Vested and Exercisable at June 30, 2015 with an aggregate intrinsic value of $3.0 million	63,709		$	22.40	0.9

The following is a reconciliation of the numerator and denominators of basic and diluted earnings per share (in thousands, except per share amounts):



	Three Months Ended June 30,					Six Months Ended June 30,
	Earnings		Shares	Per Share		Earnings		Shares	Per Share
	(Numerator)		(Denominator)	Amount		(Numerator)		(Denominator)	Amount
2015:
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	31,411	47,678	$	0.66	$	50,185	47,625	$	1.05
Effect of dilutive securities, options and non-vested shares	—		421			—		377
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	31,411	48,099	$	0.65	$	50,185	48,002	$	1.05

2014:
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	18,771	31,825	$	0.59	$	36,163	31,770	$	1.14
Effect of dilutive securities, options and non-vested shares	—		408			—		407
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	18,771	32,233	$	0.58	$	36,163	32,177	$	1.12